Belyntic Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.5M
Belyntic General Information
Description
Developer of peptide-based immunotherapies designed to treat and prevent infectious diseases and cancer. The company develops synthetic long peptide-based vaccines using a modular platform to induce targeted T-cell immune responses and integrates AI-based prediction tools, enabling biotechnology and pharmaceutical partners to develop therapeutic and prophylactic vaccine candidates.
Contact Information
Website
www.belyntic.com(Operating Subsidiary)
Corporate Office
- Scharnhorststr. 24
- 10115 Berlin
- Germany
Corporate Office
- Scharnhorststr. 24
- 10115 Berlin
- Germany
Belyntic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 17-Nov-2022 | $6.5M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 5. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 4. Later Stage VC | 01-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 30-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-May-2019 | $1.46M | $1.46M | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Sep-2016 | $896K | Completed | Startup |
Belyntic Comparisons
Industry
Financing
Details
Belyntic Competitors (28)
One of Belyntic’s 28 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| Barinthus Biotherapeutics | Formerly VC-backed | Altrincham, United Kingdom | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA | ||||
| VBI Vaccines | Corporation | Cambridge, MA |
Belyntic Patents
Belyntic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021023892-A1 | A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Inactive | 07-Aug-2019 | ||
| US-12473328-B2 | Method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Active | 07-Aug-2019 | ||
| EP-3666752-A1 | Traceless reductively cleavable linker molecules for peptide purification | Inactive | 13-Dec-2018 | ||
| WO-2020043747-A1 | Traceless reductively cleavable linker molecules for peptide purification | Inactive | 27-Aug-2018 | ||
| EP-3408257-B1 | Linker molecule and use of it in process for purification of peptides | Active | 29-Jan-2016 | C07C317/28 |
Belyntic Signals
Belyntic Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Berlin Senate Department for Economics, Energy and Public Enterprises | Government | Minority | ||
| Exist Federal Ministry of Economics and Energy | Government | |||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| Humboldt Innovation | Accelerator/Incubator | |||
| Humboldt Tech Bridge | Accelerator/Incubator |
Belyntic FAQs
-
When was Belyntic founded?
Belyntic was founded in 2011.
-
Where is Belyntic headquartered?
Belyntic is headquartered in Berlin, Germany.
-
What is the size of Belyntic?
Belyntic has 2 total employees.
-
What industry is Belyntic in?
Belyntic’s primary industry is Drug Discovery.
-
Is Belyntic a private or public company?
Belyntic is a Private company.
-
What is the current valuation of Belyntic?
The current valuation of Belyntic is .
-
What is Belyntic’s current revenue?
The current revenue for Belyntic is .
-
How much funding has Belyntic raised over time?
Belyntic has raised $2.6M.
-
Who are Belyntic’s investors?
Berlin Senate Department for Economics, Energy and Public Enterprises, Exist Federal Ministry of Economics and Energy, High-Tech Gründerfonds, Humboldt Innovation, and Humboldt Tech Bridge are 5 of 7 investors who have invested in Belyntic.
-
Who are Belyntic’s competitors?
BPS Bioscience, Selecta Biosciences, Barinthus Biotherapeutics, AsherBio, and VBI Vaccines are some of the 28 competitors of Belyntic.
-
When was Belyntic acquired?
Belyntic was acquired on 17-Nov-2022.
-
Who acquired Belyntic?
Belyntic was acquired by Mesa Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process